Product Code: ETC367645 | Publication Date: Aug 2022 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Thailand Neurology Devices Market is likely to experience consistent growth rate gains over the period 2025 to 2029. The growth rate starts at 3.23% in 2025 and reaches 12.24% by 2029.
The Neurology Devices market in Thailand is projected to grow at a stable growth rate of 4.80% by 2027, within the Asia region led by China, along with other countries like India, Japan, Australia and South Korea, collectively shaping a dynamic and evolving market environment driven by innovation and increasing adoption of emerging technologies.
The Thailand Neurology Devices Market plays a vital role in the healthcare sector, as it provides essential diagnostic and therapeutic solutions for neurological disorders. With an aging population and increasing awareness about neurological diseases, the demand for neurology devices in Thailand has been steadily rising. This market includes a wide array of products such as neuroimaging equipment, electroencephalography (EEG) devices, neurostimulation devices, and neuromonitoring equipment. Advancements in technology, coupled with collaborations between healthcare institutions and device manufacturers, have contributed to the market`s growth. The adoption of these devices is crucial for early diagnosis, treatment, and management of neurological conditions, making them a cornerstone in the Thai healthcare system.
The neurology devices market in Thailand is experiencing significant growth driven by several factors. Firstly, the aging population in the country has led to an increase in neurological disorders, such as Alzheimer`s and Parkinson`s disease, driving the demand for diagnostic and treatment devices. Secondly, advancements in neurology technology, including brain imaging and neuromodulation devices, have expanded the range of treatment options available to patients. Additionally, the healthcare sector`s focus on improving neurological care and research has boosted the adoption of neurology devices. The growing awareness of mental health issues has also contributed to the market`s growth.
The neurology devices market in Thailand faces a range of challenges. One major obstacle is the limited healthcare infrastructure and resources in rural areas, which can hinder access to neurology services and devices for a significant portion of the population. Additionally, there is a shortage of skilled neurologists and technicians, which can affect the proper utilization of advanced neurology devices. Regulatory and reimbursement issues can also slow down the introduction of innovative neurology devices in the market. Finally, the high cost of some neurology devices can be prohibitive for both healthcare facilities and patients.
The Thailand neurology devices market experienced disruptions during the COVID-19 pandemic. Non-urgent medical procedures were postponed, affecting the demand for neurology devices used in diagnostics and treatment. Supply chain challenges and delays in approvals for new medical technologies further impacted the market. However, as the healthcare system adapted to the ongoing crisis, the importance of neurology devices for diagnosing and managing neurological conditions became evident. The market began to recover, with increased investments in telehealth and remote monitoring solutions, emphasizing the need for advanced neurology devices in both hospitals and outpatient settings.
In the neurology devices market in Thailand, notable companies include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, and Siemens Healthineers. These firms manufacture a variety of neurology devices used in diagnostics and treatments.